CAS RN: 27164-46-1
Cefazolin Sodium Salt
Product Availability
Choose a grade to view its available package options.
1 package records 1 with current stock 1 grade group
Grade
98% (1)
In stock only
Batch No. Package Availability Warehouse Inquiry
Batchno.20250131
1g / 5g / 25g / 100g
Confirm by inquiry
Shanghai, Shandong, Guangdong, Hebei Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥98%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 27164-46-1
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥98%
0
Out of Stock
Beijing
Inquiry
27164-46-1 / sodium 3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
Standard CAS: 27164-46-1
Multi CAS: No
Basic Information
copy
CAS
27164-46-1 copy
Multi CAS
No copy
Molecular Formula
C14H13N8NaO4S3 copy
Molecular Weight
476.500000 copy
Exact Mass
476.011959 copy
SMILES
CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-].[Na+] copy
InChI
InChI=1S/C14H14N8O4S3.Na/c1-6-17-18-14(29-6)28-4-7-3-27-12-9(11(24)22(12)10(7)13(25)26)16-8(23)2-21-5-15-19-20-21;/h5,9,12H,2-4H2,1H3,(H,16,23)(H,25,26);/q;+1/p-1 copy
InChIKey
FLKYBGKDCCEQQM-UHFFFAOYSA-M copy
Computed Properties
copy
Structural Parameters
Heavy atom count
30 copy
Aromatic heavy atom count
10 copy
Fraction Csp3
0.43 copy
Rotatable bonds
7 copy
H-bond acceptors
13 copy
H-bond donors
1 copy
Molar refractivity
100.24 copy
TPSA
158.92 copy
LogP / Solubility
WLOGP
-4.97 copy
MLOGP
-4.34 copy
XLogP3
-4.97 copy
Consensus LogP
-4.76 copy
Log S (ESOL)
0.55 copy
Class (ESOL)
Highly soluble copy
Log S (Ali)
0.12 copy
Class (Ali)
Highly soluble copy
Log S (SILICOS-IT)
0.53 copy
Class (SILICOS-IT)
Highly soluble copy
ADME
GI absorption
Low copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-9.15 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
No copy
Egan
No copy
Muegge
No copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
4 copy